- Home
- ATNM vs CNTY Comparison
ATNM vs CNTY Comparison
Compare ATNM & CNTY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ATNM | CNTY |
|---|---|---|
| Founded | 2000 | 1992 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Hotels/Resorts |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 47.1M | 40.9M |
| IPO Year | N/A | 1993 |
Fundamental Metrics
Financial Performance| Metric | ATNM | CNTY |
|---|---|---|
| Price | $1.36 | $1.33 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 4 |
| Target Price | $4.00 | $4.00 |
| AVG Volume (30 Days) | 182.4K | ★ 190.8K |
| Earning Date | 11-14-2025 | 11-10-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $90,000.00 | ★ $572,756,000.00 |
| Revenue This Year | N/A | $2.20 |
| Revenue Next Year | N/A | $7.18 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 11.11 | N/A |
| 52 Week Low | $1.03 | $1.23 |
| 52 Week High | $2.41 | $3.31 |
Technical Indicators
Market Signals| Indicator | ATNM | CNTY |
|---|---|---|
| Relative Strength Index (RSI) | 41.07 | 40.21 |
| Support Level | $1.57 | $1.31 |
| Resistance Level | $1.72 | $1.47 |
| Average True Range (ATR) | 0.10 | 0.09 |
| MACD | -0.03 | 0.02 |
| Stochastic Oscillator | 0.00 | 36.68 |
Price Performance
Historical ComparisonAbout ATNM Actinium Pharmaceuticals Inc. (Delaware)
Actinium Pharmaceuticals Inc is a biopharmaceutical company engaged in the development of radiotherapies for patients with cancers lacking effective treatment options. The company's proprietary technology platform utilizes monoclonal antibodies to deliver radioisotopes directly to cells of interest to kill those cells safely and effectively. Its product candidates are Iomab-B, an antibody-drug construct containing iodine 131 (I-131), used for hematopoietic stem cells transplantation in various indications, and Actimab-A, an antibody-drug construct containing actinium 225 (Ac-225), currently in human clinical trials for acute myeloid leukemia.
About CNTY Century Casinos Inc.
Century Casinos Inc is a casino entertainment company that develops and operates gaming establishments as well as related lodging, restaurants, horse racing (including off-track betting), and entertainment facilities in North America. The company has three reportable segments based on the geographical locations in which its casinos operate; United States; Century Casino & Hotel-Central City, and Century Casino & Hotel-Cripple Creek in Colorado, Mountaineer Casino, Racetrack & Resort in West Virginia, and Century Casino Caruthersville, and Century Casino Cape Girardeau in Missouri, Canada; Century Casino & Hotel, Century Casino St. Albert, Century Mile Racetrack in Edmonton and Casino Century Downs Racetrack and Casino in Calgary, and Poland; Casinos Poland.